Friedman's excellent discussion of drugs associated with the floppy-iris syndrome1 sends an important alert to readers unfamiliar with the association, with 1 exception; it assiduously avoids listing brand (proprietary) names. During history taking, patients do not ordinarily introduce a generic term such as tamsulosin; they say “Doctor, I am taking Flomax.” It is at that point that the ophthalmologist should instruct the patient to remind the cataract surgeon about that drug, or to highlight it in the chart if the examiner plans to perform the cataract surgery. After inquiring about medications, one should ask about health food supplements. Substances such as saw palmetto may only be disclosed after specifically inquiring about items obtained from a health food store.
The Archives’ “Instructions for Authors” suggests that the use of brand names in a scientific article may sometimes be appropriate. Not every practitioner has the time or inclination to look up the trade name corresponding to each nonproprietary name. As a service to the ophthalmic community, the following Table lists the brand names linked to the floppy-iris syndrome.
Correspondence: Dr Charles, Department of Ophthalmology, New York University Medical Center, 550 First Ave, New York, NY 10016 (norman.charles@med.nyu.edu).
Financial Disclosure: None reported.
Editor's Note: The nonproprietary name of a drug is preferred in almost all instances. If it is necessary to include the proprietary (brand or trade) name for reproduction or interpretation of the study, the proprietary name should be given parenthetically following the nonproprietary name, at first mention in the abstract, text, and each figure or table in which it appears. In addition, the proprietary and supplier's name and location should be given in the “Methods” section. In the case in which a manuscript is comparing various brands of a single product, or in which an adverse event is described that might be unique to a single brand of product, both the proprietary and nonproprietary names should appear at first mention and the proprietary name(s) should be used thereafter.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Archives of Ophthalmology editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.